#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Micronutrients are essential to orchestrate all physiological functions .
2-1	16-30	Micronutrients	substance	new	ana	3-2
2-2	31-34	are	_	_	_	_
2-3	35-44	essential	_	_	_	_
2-4	45-47	to	_	_	_	_
2-5	48-59	orchestrate	_	_	_	_
2-6	60-63	all	abstract[3]	new[3]	_	_
2-7	64-77	physiological	abstract[3]	new[3]	_	_
2-8	78-87	functions	abstract[3]	new[3]	_	_
2-9	88-89	.	_	_	_	_

#Text=Among them , iodine ( I ) plays a unique role because it is the main component of the thyroid hormones , i. e. , thyroxine ( T4 ) and triiodothyronine ( T3 ) .
3-1	90-95	Among	_	_	_	_
3-2	96-100	them	substance	giv	_	_
3-3	101-102	,	_	_	_	_
3-4	103-109	iodine	substance	new	coref	8-16
3-5	110-111	(	_	_	_	_
3-6	112-113	I	person	acc	ana	4-13
3-7	114-115	)	_	_	_	_
3-8	116-121	plays	_	_	_	_
3-9	122-123	a	abstract[7]	new[7]	ana	3-13[0_7]
3-10	124-130	unique	abstract[7]	new[7]	_	_
3-11	131-135	role	abstract[7]	new[7]	_	_
3-12	136-143	because	_	_	_	_
3-13	144-146	it	abstract	giv	coref	3-15[9_0]
3-14	147-149	is	_	_	_	_
3-15	150-153	the	abstract[9]	giv[9]	_	_
3-16	154-158	main	abstract[9]	giv[9]	_	_
3-17	159-168	component	abstract[9]	giv[9]	_	_
3-18	169-171	of	abstract[9]	giv[9]	_	_
3-19	172-175	the	abstract[9]|substance[11]	giv[9]|new[11]	_	_
3-20	176-183	thyroid	abstract[9]|object|substance[11]	giv[9]|new|new[11]	coref	4-3
3-21	184-192	hormones	abstract[9]|substance[11]	giv[9]|new[11]	_	_
3-22	193-194	,	_	_	_	_
3-23	195-197	i.	_	_	_	_
3-24	198-200	e.	_	_	_	_
3-25	201-202	,	_	_	_	_
3-26	203-212	thyroxine	substance	new	_	_
3-27	213-214	(	_	_	_	_
3-28	215-217	T4	abstract	new	_	_
3-29	218-219	)	_	_	_	_
3-30	220-223	and	_	_	_	_
3-31	224-240	triiodothyronine	substance	new	_	_
3-32	241-242	(	_	_	_	_
3-33	243-245	T3	abstract	new	_	_
3-34	246-247	)	_	_	_	_
3-35	248-249	.	_	_	_	_

#Text=Since the thyroid gland regulates many metabolic processes , the extent of I requirement strongly depends on the age and stage of development of the individual .
4-1	250-255	Since	_	_	_	_
4-2	256-259	the	place[17]	new[17]	coref	5-14[30_17]
4-3	260-267	thyroid	object|place[17]	giv|new[17]	coref	5-15
4-4	268-273	gland	place[17]	new[17]	_	_
4-5	274-283	regulates	_	_	_	_
4-6	284-288	many	abstract[19]	new[19]	_	_
4-7	289-298	metabolic	person|abstract[19]	new|new[19]	coref	4-25[26_0]
4-8	299-308	processes	abstract[19]	new[19]	_	_
4-9	309-310	,	_	_	_	_
4-10	311-314	the	abstract[20]	new[20]	_	_
4-11	315-321	extent	abstract[20]	new[20]	_	_
4-12	322-324	of	abstract[20]	new[20]	_	_
4-13	325-326	I	abstract[20]|person|abstract[22]	new[20]|giv|new[22]	ana	6-10
4-14	327-338	requirement	abstract[20]|abstract[22]	new[20]|new[22]	_	_
4-15	339-347	strongly	_	_	_	_
4-16	348-355	depends	_	_	_	_
4-17	356-358	on	_	_	_	_
4-18	359-362	the	abstract[23]	new[23]	_	_
4-19	363-366	age	abstract[23]	new[23]	_	_
4-20	367-370	and	_	_	_	_
4-21	371-376	stage	abstract[24]	new[24]	ana	5-4[27_24]
4-22	377-379	of	abstract[24]	new[24]	_	_
4-23	380-391	development	abstract[24]|abstract[25]	new[24]|new[25]	coref	5-26[33_25]
4-24	392-394	of	abstract[24]|abstract[25]	new[24]|new[25]	_	_
4-25	395-398	the	abstract[24]|abstract[25]|person[26]	new[24]|new[25]|giv[26]	_	_
4-26	399-409	individual	abstract[24]|abstract[25]|person[26]	new[24]|new[25]|giv[26]	_	_
4-27	410-411	.	_	_	_	_

#Text=Thus , when the I demand is not satisfied , reduced functionality of the thyroid gland could occur ( hypothyroidism ) with negative consequences for proper mental development , body growth , and fertility .
5-1	412-416	Thus	_	_	_	_
5-2	417-418	,	_	_	_	_
5-3	419-423	when	_	_	_	_
5-4	424-427	the	abstract[27]	giv[27]	_	_
5-5	428-429	I	abstract[27]	giv[27]	_	_
5-6	430-436	demand	_	_	_	_
5-7	437-439	is	_	_	_	_
5-8	440-443	not	_	_	_	_
5-9	444-453	satisfied	_	_	_	_
5-10	454-455	,	_	_	_	_
5-11	456-463	reduced	abstract[28]	new[28]	_	_
5-12	464-477	functionality	abstract[28]	new[28]	_	_
5-13	478-480	of	abstract[28]	new[28]	_	_
5-14	481-484	the	abstract[28]|object[30]	new[28]|giv[30]	_	_
5-15	485-492	thyroid	abstract[28]|object|object[30]	new[28]|giv|giv[30]	_	_
5-16	493-498	gland	abstract[28]|object[30]	new[28]|giv[30]	_	_
5-17	499-504	could	_	_	_	_
5-18	505-510	occur	_	_	_	_
5-19	511-512	(	_	_	_	_
5-20	513-527	hypothyroidism	abstract	new	_	_
5-21	528-529	)	_	_	_	_
5-22	530-534	with	_	_	_	_
5-23	535-543	negative	abstract[32]	new[32]	_	_
5-24	544-556	consequences	abstract[32]	new[32]	_	_
5-25	557-560	for	abstract[32]	new[32]	_	_
5-26	561-567	proper	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
5-27	568-574	mental	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
5-28	575-586	development	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
5-29	587-588	,	abstract[32]	new[32]	_	_
5-30	589-593	body	abstract[32]|object|abstract[35]	new[32]|new|new[35]	_	_
5-31	594-600	growth	abstract[32]|abstract[35]	new[32]|new[35]	_	_
5-32	601-602	,	abstract[32]	new[32]	_	_
5-33	603-606	and	abstract[32]	new[32]	_	_
5-34	607-616	fertility	abstract[32]|abstract	new[32]|new	_	_
5-35	617-618	.	_	_	_	_

#Text=For these reason , diet is often integrated with I supplements , generally provided through iodized salt .
6-1	619-622	For	_	_	_	_
6-2	623-628	these	abstract[37]	new[37]	coref	9-2[80_37]
6-3	629-635	reason	abstract[37]	new[37]	_	_
6-4	636-637	,	_	_	_	_
6-5	638-642	diet	abstract	new	coref	15-29[150_0]
6-6	643-645	is	_	_	_	_
6-7	646-651	often	_	_	_	_
6-8	652-662	integrated	_	_	_	_
6-9	663-667	with	_	_	_	_
6-10	668-669	I	person|substance[40]	giv|new[40]	ana	7-8
6-11	670-681	supplements	substance[40]	new[40]	_	_
6-12	682-683	,	_	_	_	_
6-13	684-693	generally	_	_	_	_
6-14	694-702	provided	_	_	_	_
6-15	703-710	through	_	_	_	_
6-16	711-718	iodized	substance[41]	new[41]	_	_
6-17	719-723	salt	substance[41]	new[41]	_	_
6-18	724-725	.	_	_	_	_

#Text=For infants , milk constitutes the only I source ; therefore , the dietary calibration of this micronutrients in dairy animals assumes relevant importance in order to obtain I-rich milk without inducing variations in animal performances .
7-1	726-729	For	_	_	_	_
7-2	730-737	infants	person	new	_	_
7-3	738-739	,	_	_	_	_
7-4	740-744	milk	substance	new	coref	7-29[52_0]
7-5	745-756	constitutes	_	_	_	_
7-6	757-760	the	abstract[45]	new[45]	_	_
7-7	761-765	only	abstract[45]	new[45]	_	_
7-8	766-767	I	person|abstract[45]	giv|new[45]	ana	8-5
7-9	768-774	source	abstract[45]	new[45]	_	_
7-10	775-776	;	_	_	_	_
7-11	777-786	therefore	_	_	_	_
7-12	787-788	,	_	_	_	_
7-13	789-792	the	abstract[47]	new[47]	_	_
7-14	793-800	dietary	abstract|abstract[47]	new|new[47]	coref	17-38
7-15	801-812	calibration	abstract[47]	new[47]	_	_
7-16	813-815	of	abstract[47]	new[47]	_	_
7-17	816-820	this	abstract[47]|abstract[48]	new[47]|new[48]	_	_
7-18	821-835	micronutrients	abstract[47]|abstract[48]	new[47]|new[48]	_	_
7-19	836-838	in	abstract[47]|abstract[48]	new[47]|new[48]	_	_
7-20	839-844	dairy	abstract[47]|abstract[48]|person|animal[50]	new[47]|new[48]|new|new[50]	coref|coref	10-15[0_50]|10-43
7-21	845-852	animals	abstract[47]|abstract[48]|animal[50]	new[47]|new[48]|new[50]	_	_
7-22	853-860	assumes	_	_	_	_
7-23	861-869	relevant	abstract[51]	new[51]	_	_
7-24	870-880	importance	abstract[51]	new[51]	_	_
7-25	881-883	in	_	_	_	_
7-26	884-889	order	_	_	_	_
7-27	890-892	to	_	_	_	_
7-28	893-899	obtain	_	_	_	_
7-29	900-906	I-rich	substance[52]	giv[52]	coref	10-34[103_52]
7-30	907-911	milk	substance[52]	giv[52]	_	_
7-31	912-919	without	_	_	_	_
7-32	920-928	inducing	_	_	_	_
7-33	929-939	variations	abstract[53]	new[53]	_	_
7-34	940-942	in	abstract[53]	new[53]	_	_
7-35	943-949	animal	abstract[53]|animal|event[55]	new[53]|new|new[55]	coref|coref	8-2|10-11[95_55]
7-36	950-962	performances	abstract[53]|event[55]	new[53]|new[55]	_	_
7-37	963-964	.	_	_	_	_

#Text=In animal husbandry , I supplementation as calcium iodate , sodium iodide , and other iodine compounds is needed since the native iodine content of plant straight feed-stuffs is low ; moreover , the increasing use of rapeseed meal ( RSM ) in livestock diets is associated with the intake of glucosinolates , which are known to be iodine antagonists inhibiting the activity of sodium iodide symporter .
8-1	965-967	In	_	_	_	_
8-2	968-974	animal	animal|abstract[57]	giv|new[57]	_	_
8-3	975-984	husbandry	abstract[57]	new[57]	_	_
8-4	985-986	,	_	_	_	_
8-5	987-988	I	person	giv	ana	9-18
8-6	989-1004	supplementation	_	_	_	_
8-7	1005-1007	as	_	_	_	_
8-8	1008-1015	calcium	substance	new	_	_
8-9	1016-1022	iodate	_	_	_	_
8-10	1023-1024	,	_	_	_	_
8-11	1025-1031	sodium	substance	new	coref	8-65
8-12	1032-1038	iodide	_	_	_	_
8-13	1039-1040	,	_	_	_	_
8-14	1041-1044	and	_	_	_	_
8-15	1045-1050	other	substance[62]	new[62]	_	_
8-16	1051-1057	iodine	substance|substance[62]	giv|new[62]	coref	8-23
8-17	1058-1067	compounds	substance[62]	new[62]	_	_
8-18	1068-1070	is	_	_	_	_
8-19	1071-1077	needed	_	_	_	_
8-20	1078-1083	since	_	_	_	_
8-21	1084-1087	the	abstract[64]	new[64]	coref	11-14[115_64]
8-22	1088-1094	native	abstract[64]	new[64]	_	_
8-23	1095-1101	iodine	substance|abstract[64]	giv|new[64]	coref	8-59
8-24	1102-1109	content	abstract[64]	new[64]	_	_
8-25	1110-1112	of	abstract[64]	new[64]	_	_
8-26	1113-1118	plant	abstract[64]|plant|plant[66]	new[64]|new|new[66]	_	_
8-27	1119-1127	straight	abstract[64]|plant[66]	new[64]|new[66]	_	_
8-28	1128-1139	feed-stuffs	abstract[64]|plant[66]	new[64]|new[66]	_	_
8-29	1140-1142	is	_	_	_	_
8-30	1143-1146	low	_	_	_	_
8-31	1147-1148	;	_	_	_	_
8-32	1149-1157	moreover	_	_	_	_
8-33	1158-1159	,	_	_	_	_
8-34	1160-1163	the	abstract[67]	new[67]	_	_
8-35	1164-1174	increasing	abstract[67]	new[67]	_	_
8-36	1175-1178	use	abstract[67]	new[67]	_	_
8-37	1179-1181	of	abstract[67]	new[67]	_	_
8-38	1182-1190	rapeseed	abstract[67]|substance[68]	new[67]|new[68]	appos	8-41[0_68]
8-39	1191-1195	meal	abstract[67]|substance[68]	new[67]|new[68]	_	_
8-40	1196-1197	(	_	_	_	_
8-41	1198-1201	RSM	substance	giv	_	_
8-42	1202-1203	)	_	_	_	_
8-43	1204-1206	in	_	_	_	_
8-44	1207-1216	livestock	animal|object[71]	new|new[71]	coref	10-41[106_71]
8-45	1217-1222	diets	object[71]	new[71]	_	_
8-46	1223-1225	is	_	_	_	_
8-47	1226-1236	associated	_	_	_	_
8-48	1237-1241	with	_	_	_	_
8-49	1242-1245	the	event[72]	new[72]	_	_
8-50	1246-1252	intake	event[72]	new[72]	_	_
8-51	1253-1255	of	event[72]	new[72]	_	_
8-52	1256-1270	glucosinolates	event[72]|substance	new[72]|new	_	_
8-53	1271-1272	,	_	_	_	_
8-54	1273-1278	which	_	_	_	_
8-55	1279-1282	are	_	_	_	_
8-56	1283-1288	known	_	_	_	_
8-57	1289-1291	to	_	_	_	_
8-58	1292-1294	be	_	_	_	_
8-59	1295-1301	iodine	abstract|abstract[75]	giv|new[75]	coref	11-16
8-60	1302-1313	antagonists	abstract[75]	new[75]	_	_
8-61	1314-1324	inhibiting	_	_	_	_
8-62	1325-1328	the	abstract[76]	new[76]	_	_
8-63	1329-1337	activity	abstract[76]	new[76]	_	_
8-64	1338-1340	of	abstract[76]	new[76]	_	_
8-65	1341-1347	sodium	abstract[76]|substance|abstract[79]	new[76]|giv|new[79]	_	_
8-66	1348-1354	iodide	abstract[76]|place|abstract[79]	new[76]|new|new[79]	coref	14-11
8-67	1355-1364	symporter	abstract[76]|abstract[79]	new[76]|new[79]	_	_
8-68	1365-1366	.	_	_	_	_

#Text=For this reason , the European community has recently brought to 5 mg/kg the maximum level of I supplementation for milk-producing ruminants ( milk intended for human consumption ) , while it remained at 10 mg/kg of complete feed for other ruminant categories .
9-1	1367-1370	For	_	_	_	_
9-2	1371-1375	this	abstract[80]	giv[80]	_	_
9-3	1376-1382	reason	abstract[80]	giv[80]	_	_
9-4	1383-1384	,	_	_	_	_
9-5	1385-1388	the	organization[81]	new[81]	_	_
9-6	1389-1397	European	organization[81]	new[81]	_	_
9-7	1398-1407	community	organization[81]	new[81]	_	_
9-8	1408-1411	has	_	_	_	_
9-9	1412-1420	recently	_	_	_	_
9-10	1421-1428	brought	_	_	_	_
9-11	1429-1431	to	_	_	_	_
9-12	1432-1433	5	quantity[82]	new[82]	_	_
9-13	1434-1439	mg/kg	quantity[82]	new[82]	_	_
9-14	1440-1443	the	quantity[83]	new[83]	ana	9-32[0_83]
9-15	1444-1451	maximum	quantity[83]	new[83]	_	_
9-16	1452-1457	level	quantity[83]	new[83]	_	_
9-17	1458-1460	of	quantity[83]	new[83]	_	_
9-18	1461-1462	I	quantity[83]|person|substance[85]	new[83]|giv|new[85]	ana|coref	10-18|10-17[98_85]
9-19	1463-1478	supplementation	quantity[83]|substance[85]	new[83]|new[85]	_	_
9-20	1479-1482	for	quantity[83]|substance[85]	new[83]|new[85]	_	_
9-21	1483-1497	milk-producing	quantity[83]|substance[85]|substance[86]	new[83]|new[85]|new[86]	appos	9-24[0_86]
9-22	1498-1507	ruminants	quantity[83]|substance[85]|substance[86]	new[83]|new[85]|new[86]	_	_
9-23	1508-1509	(	_	_	_	_
9-24	1510-1514	milk	substance	giv	coref	11-7[110_0]
9-25	1515-1523	intended	_	_	_	_
9-26	1524-1527	for	_	_	_	_
9-27	1528-1533	human	abstract[88]	new[88]	_	_
9-28	1534-1545	consumption	abstract[88]	new[88]	_	_
9-29	1546-1547	)	_	_	_	_
9-30	1548-1549	,	_	_	_	_
9-31	1550-1555	while	_	_	_	_
9-32	1556-1558	it	quantity	giv	_	_
9-33	1559-1567	remained	_	_	_	_
9-34	1568-1570	at	_	_	_	_
9-35	1571-1573	10	abstract[90]	new[90]	_	_
9-36	1574-1579	mg/kg	abstract[90]	new[90]	_	_
9-37	1580-1582	of	abstract[90]	new[90]	_	_
9-38	1583-1591	complete	abstract[90]|abstract[91]	new[90]|new[91]	_	_
9-39	1592-1596	feed	abstract[90]|abstract[91]	new[90]|new[91]	_	_
9-40	1597-1600	for	abstract[90]|abstract[91]	new[90]|new[91]	_	_
9-41	1601-1606	other	abstract[90]|abstract[91]|abstract[93]	new[90]|new[91]|new[93]	_	_
9-42	1607-1615	ruminant	abstract[90]|abstract[91]|abstract|abstract[93]	new[90]|new[91]|new|new[93]	_	_
9-43	1616-1626	categories	abstract[90]|abstract[91]|abstract[93]	new[90]|new[91]|new[93]	_	_
9-44	1627-1628	.	_	_	_	_

#Text=Consequently , several studies have been carried out to evaluate the productive performances in animals fed the I supplementation . Weiss et al. showed that I concentration increased in serum but not in milk after supplementation of this element in diets of dairy cows .
10-1	1629-1641	Consequently	_	_	_	_
10-2	1642-1643	,	_	_	_	_
10-3	1644-1651	several	event[94]	new[94]	coref	11-4[0_94]
10-4	1652-1659	studies	event[94]	new[94]	_	_
10-5	1660-1664	have	_	_	_	_
10-6	1665-1669	been	_	_	_	_
10-7	1670-1677	carried	_	_	_	_
10-8	1678-1681	out	_	_	_	_
10-9	1682-1684	to	_	_	_	_
10-10	1685-1693	evaluate	_	_	_	_
10-11	1694-1697	the	event[95]	giv[95]	_	_
10-12	1698-1708	productive	event[95]	giv[95]	_	_
10-13	1709-1721	performances	event[95]	giv[95]	_	_
10-14	1722-1724	in	event[95]	giv[95]	_	_
10-15	1725-1732	animals	event[95]|animal	giv[95]|giv	_	_
10-16	1733-1736	fed	_	_	_	_
10-17	1737-1740	the	substance[98]	giv[98]	coref	10-36[104_98]
10-18	1741-1742	I	person|substance[98]	giv|giv[98]	ana	10-26
10-19	1743-1758	supplementation	substance[98]	giv[98]	_	_
10-20	1759-1760	.	_	_	_	_
10-21	1761-1766	Weiss	person	new	_	_
10-22	1767-1769	et	_	_	_	_
10-23	1770-1773	al.	_	_	_	_
10-24	1774-1780	showed	_	_	_	_
10-25	1781-1785	that	_	_	_	_
10-26	1786-1787	I	person	giv	ana	11-11
10-27	1788-1801	concentration	abstract	new	_	_
10-28	1802-1811	increased	_	_	_	_
10-29	1812-1814	in	_	_	_	_
10-30	1815-1820	serum	substance	new	_	_
10-31	1821-1824	but	_	_	_	_
10-32	1825-1828	not	_	_	_	_
10-33	1829-1831	in	_	_	_	_
10-34	1832-1836	milk	substance[103]	giv[103]	coref	11-15[0_103]
10-35	1837-1842	after	substance[103]	giv[103]	_	_
10-36	1843-1858	supplementation	substance[103]|substance[104]	giv[103]|giv[104]	coref	11-12[0_104]
10-37	1859-1861	of	substance[103]|substance[104]	giv[103]|giv[104]	_	_
10-38	1862-1866	this	substance[103]|substance[104]|substance[105]	giv[103]|giv[104]|new[105]	_	_
10-39	1867-1874	element	substance[103]|substance[104]|substance[105]	giv[103]|giv[104]|new[105]	_	_
10-40	1875-1877	in	substance[103]|substance[104]	giv[103]|giv[104]	_	_
10-41	1878-1883	diets	substance[103]|substance[104]|object[106]	giv[103]|giv[104]|giv[106]	_	_
10-42	1884-1886	of	substance[103]|substance[104]|object[106]	giv[103]|giv[104]|giv[106]	_	_
10-43	1887-1892	dairy	substance[103]|substance[104]|object[106]|person|animal[108]	giv[103]|giv[104]|giv[106]|giv|new[108]	coref|coref	16-19|16-19[160_108]
10-44	1893-1897	cows	substance[103]|substance[104]|object[106]|animal[108]	giv[103]|giv[104]|giv[106]|new[108]	_	_
10-45	1898-1899	.	_	_	_	_

#Text=In contrast , studies performed in small ruminants showed that I supplementation doubled the milk iodine content when compared with the control group , even though no evident effect was observed in the milk gross composition .
11-1	1900-1902	In	_	_	_	_
11-2	1903-1911	contrast	_	_	_	_
11-3	1912-1913	,	_	_	_	_
11-4	1914-1921	studies	event	giv	coref	17-30[171_0]
11-5	1922-1931	performed	_	_	_	_
11-6	1932-1934	in	_	_	_	_
11-7	1935-1940	small	substance[110]	giv[110]	coref	17-23[168_110]
11-8	1941-1950	ruminants	substance[110]	giv[110]	_	_
11-9	1951-1957	showed	_	_	_	_
11-10	1958-1962	that	_	_	_	_
11-11	1963-1964	I	person	giv	ana	12-1
11-12	1965-1980	supplementation	substance	giv	coref	12-2
11-13	1981-1988	doubled	_	_	_	_
11-14	1989-1992	the	abstract[115]	giv[115]	_	_
11-15	1993-1997	milk	substance|abstract[115]	giv|giv[115]	coref	11-33[118_0]
11-16	1998-2004	iodine	substance|abstract[115]	giv|giv[115]	coref	17-39
11-17	2005-2012	content	abstract[115]	giv[115]	_	_
11-18	2013-2017	when	_	_	_	_
11-19	2018-2026	compared	_	_	_	_
11-20	2027-2031	with	_	_	_	_
11-21	2032-2035	the	abstract[116]	new[116]	_	_
11-22	2036-2043	control	abstract[116]	new[116]	_	_
11-23	2044-2049	group	abstract[116]	new[116]	_	_
11-24	2050-2051	,	_	_	_	_
11-25	2052-2056	even	_	_	_	_
11-26	2057-2063	though	_	_	_	_
11-27	2064-2066	no	abstract[117]	new[117]	_	_
11-28	2067-2074	evident	abstract[117]	new[117]	_	_
11-29	2075-2081	effect	abstract[117]	new[117]	_	_
11-30	2082-2085	was	_	_	_	_
11-31	2086-2094	observed	_	_	_	_
11-32	2095-2097	in	_	_	_	_
11-33	2098-2101	the	substance[118]	giv[118]	coref	17-23[0_118]
11-34	2102-2106	milk	substance[118]	giv[118]	_	_
11-35	2107-2112	gross	substance[118]	giv[118]	_	_
11-36	2113-2124	composition	substance[118]|abstract	giv[118]|new	_	_
11-37	2125-2126	.	_	_	_	_

#Text=I supplementation showed also beneficial effects on healthy status .
12-1	2127-2128	I	person	giv	ana	15-19
12-2	2129-2144	supplementation	substance	giv	coref	14-9[135_0]
12-3	2145-2151	showed	_	_	_	_
12-4	2152-2156	also	_	_	_	_
12-5	2157-2167	beneficial	abstract[122]	new[122]	coref	15-25[149_122]
12-6	2168-2175	effects	abstract[122]	new[122]	_	_
12-7	2176-2178	on	abstract[122]	new[122]	_	_
12-8	2179-2186	healthy	abstract[122]|abstract[123]	new[122]|new[123]	_	_
12-9	2187-2193	status	abstract[122]|abstract[123]	new[122]|new[123]	_	_
12-10	2194-2195	.	_	_	_	_

#Text=Indeed , early study on feedlot cattle demonstrated an increased resistance to foot rot , which is due to improved phagocytic cell function .
13-1	2196-2202	Indeed	_	_	_	_
13-2	2203-2204	,	_	_	_	_
13-3	2205-2210	early	abstract[124]	new[124]	_	_
13-4	2211-2216	study	abstract[124]	new[124]	_	_
13-5	2217-2219	on	abstract[124]	new[124]	_	_
13-6	2220-2227	feedlot	abstract[124]|animal|animal[126]	new[124]|new|new[126]	_	_
13-7	2228-2234	cattle	abstract[124]|animal[126]	new[124]|new[126]	_	_
13-8	2235-2247	demonstrated	_	_	_	_
13-9	2248-2250	an	abstract[127]	new[127]	_	_
13-10	2251-2260	increased	abstract[127]	new[127]	_	_
13-11	2261-2271	resistance	abstract[127]	new[127]	_	_
13-12	2272-2274	to	abstract[127]	new[127]	_	_
13-13	2275-2279	foot	abstract[127]	new[127]	_	_
13-14	2280-2283	rot	abstract[127]|event	new[127]|new	ana	14-3
13-15	2284-2285	,	_	_	_	_
13-16	2286-2291	which	_	_	_	_
13-17	2292-2294	is	_	_	_	_
13-18	2295-2298	due	_	_	_	_
13-19	2299-2301	to	_	_	_	_
13-20	2302-2310	improved	abstract[130]	new[130]	_	_
13-21	2311-2321	phagocytic	abstract[130]	new[130]	_	_
13-22	2322-2326	cell	object|abstract[130]	new|new[130]	_	_
13-23	2327-2335	function	abstract[130]	new[130]	_	_
13-24	2336-2337	.	_	_	_	_

#Text=Moreover , it was shown in lambs that high-dose potassium iodide supplementation can be effective to decrease the severity of airway viral infections , supposedly through the augmentation of mucosal oxidative defenses .
14-1	2338-2346	Moreover	_	_	_	_
14-2	2347-2348	,	_	_	_	_
14-3	2349-2351	it	event	giv	_	_
14-4	2352-2355	was	_	_	_	_
14-5	2356-2361	shown	_	_	_	_
14-6	2362-2364	in	_	_	_	_
14-7	2365-2370	lambs	animal	new	_	_
14-8	2371-2375	that	_	_	_	_
14-9	2376-2385	high-dose	substance[135]	giv[135]	coref	15-19[147_135]
14-10	2386-2395	potassium	substance|substance[135]	new|giv[135]	_	_
14-11	2396-2402	iodide	place|substance[135]	giv|giv[135]	_	_
14-12	2403-2418	supplementation	substance[135]	giv[135]	_	_
14-13	2419-2422	can	_	_	_	_
14-14	2423-2425	be	_	_	_	_
14-15	2426-2435	effective	_	_	_	_
14-16	2436-2438	to	_	_	_	_
14-17	2439-2447	decrease	_	_	_	_
14-18	2448-2451	the	abstract[136]	new[136]	_	_
14-19	2452-2460	severity	abstract[136]	new[136]	_	_
14-20	2461-2463	of	abstract[136]	new[136]	_	_
14-21	2464-2470	airway	abstract[136]|place|abstract[139]	new[136]|new|new[139]	_	_
14-22	2471-2476	viral	abstract[136]|object|abstract[139]	new[136]|new|new[139]	_	_
14-23	2477-2487	infections	abstract[136]|abstract[139]	new[136]|new[139]	_	_
14-24	2488-2489	,	_	_	_	_
14-25	2490-2500	supposedly	abstract[140]	new[140]	_	_
14-26	2501-2508	through	abstract[140]	new[140]	_	_
14-27	2509-2512	the	abstract[140]	new[140]	_	_
14-28	2513-2525	augmentation	abstract[140]	new[140]	_	_
14-29	2526-2528	of	abstract[140]	new[140]	_	_
14-30	2529-2536	mucosal	abstract[140]|abstract[142]	new[140]|new[142]	_	_
14-31	2537-2546	oxidative	abstract[140]|abstract|abstract[142]	new[140]|new|new[142]	_	_
14-32	2547-2555	defenses	abstract[140]|abstract[142]	new[140]|new[142]	_	_
14-33	2556-2557	.	_	_	_	_

#Text=Recently , the RNA-sequencing approach was shown to be useful to elucidate which molecular pathways are affected by I supplementation in sheeps and showed the positive effects of olive pomace-supplemented diet on inflammation and cholesterol in laying hens .
15-1	2558-2566	Recently	_	_	_	_
15-2	2567-2568	,	_	_	_	_
15-3	2569-2572	the	abstract[144]	new[144]	_	_
15-4	2573-2587	RNA-sequencing	abstract|abstract[144]	new|new[144]	_	_
15-5	2588-2596	approach	abstract[144]	new[144]	_	_
15-6	2597-2600	was	_	_	_	_
15-7	2601-2606	shown	_	_	_	_
15-8	2607-2609	to	_	_	_	_
15-9	2610-2612	be	_	_	_	_
15-10	2613-2619	useful	_	_	_	_
15-11	2620-2622	to	_	_	_	_
15-12	2623-2632	elucidate	_	_	_	_
15-13	2633-2638	which	abstract[145]	new[145]	coref	17-10[163_145]
15-14	2639-2648	molecular	abstract[145]	new[145]	_	_
15-15	2649-2657	pathways	abstract[145]	new[145]	_	_
15-16	2658-2661	are	_	_	_	_
15-17	2662-2670	affected	_	_	_	_
15-18	2671-2673	by	_	_	_	_
15-19	2674-2675	I	person|substance[147]	giv|giv[147]	ana|coref	16-13|16-13[157_147]
15-20	2676-2691	supplementation	substance[147]	giv[147]	_	_
15-21	2692-2694	in	substance[147]	giv[147]	_	_
15-22	2695-2701	sheeps	substance[147]|animal	giv[147]|new	_	_
15-23	2702-2705	and	_	_	_	_
15-24	2706-2712	showed	_	_	_	_
15-25	2713-2716	the	abstract[149]	giv[149]	_	_
15-26	2717-2725	positive	abstract[149]	giv[149]	_	_
15-27	2726-2733	effects	abstract[149]	giv[149]	_	_
15-28	2734-2736	of	abstract[149]	giv[149]	_	_
15-29	2737-2742	olive	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
15-30	2743-2762	pomace-supplemented	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
15-31	2763-2767	diet	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
15-32	2768-2770	on	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
15-33	2771-2783	inflammation	abstract[149]|abstract[150]|abstract	giv[149]|giv[150]|new	_	_
15-34	2784-2787	and	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
15-35	2788-2799	cholesterol	abstract[149]|abstract[150]|substance	giv[149]|giv[150]|new	_	_
15-36	2800-2802	in	_	_	_	_
15-37	2803-2809	laying	_	_	_	_
15-38	2810-2814	hens	animal	new	_	_
15-39	2815-2816	.	_	_	_	_

#Text=However , to date , little is known about the effects of I supplementation on transcriptomic profiles in dairy cows .
16-1	2817-2824	However	_	_	_	_
16-2	2825-2826	,	_	_	_	_
16-3	2827-2829	to	_	_	_	_
16-4	2830-2834	date	time	new	_	_
16-5	2835-2836	,	_	_	_	_
16-6	2837-2843	little	_	_	_	_
16-7	2844-2846	is	_	_	_	_
16-8	2847-2852	known	_	_	_	_
16-9	2853-2858	about	_	_	_	_
16-10	2859-2862	the	abstract[155]	new[155]	_	_
16-11	2863-2870	effects	abstract[155]	new[155]	_	_
16-12	2871-2873	of	abstract[155]	new[155]	_	_
16-13	2874-2875	I	abstract[155]|person|substance[157]	new[155]|giv|giv[157]	ana|coref	17-15|17-15[165_157]
16-14	2876-2891	supplementation	abstract[155]|substance[157]	new[155]|giv[157]	_	_
16-15	2892-2894	on	abstract[155]|substance[157]	new[155]|giv[157]	_	_
16-16	2895-2909	transcriptomic	abstract[155]|substance[157]|object[158]	new[155]|giv[157]|new[158]	_	_
16-17	2910-2918	profiles	abstract[155]|substance[157]|object[158]	new[155]|giv[157]|new[158]	_	_
16-18	2919-2921	in	abstract[155]|substance[157]|object[158]	new[155]|giv[157]|new[158]	_	_
16-19	2922-2927	dairy	abstract[155]|substance[157]|object[158]|animal|animal[160]	new[155]|giv[157]|new[158]|giv|giv[160]	_	_
16-20	2928-2932	cows	abstract[155]|substance[157]|object[158]|animal[160]	new[155]|giv[157]|new[158]|giv[160]	_	_
16-21	2933-2934	.	_	_	_	_

#Text=Moreover , we tried to correlate the information concerning the signaling pathways influenced by I supplementation , with the qualitative parameters of milk and derivatives , taking into account those studies in which it was shown that dietary iodine supplementation in ruminants contributes to an improvement in the quality of dairy products .
17-1	2935-2943	Moreover	_	_	_	_
17-2	2944-2945	,	_	_	_	_
17-3	2946-2948	we	person	acc	_	_
17-4	2949-2954	tried	_	_	_	_
17-5	2955-2957	to	_	_	_	_
17-6	2958-2967	correlate	_	_	_	_
17-7	2968-2971	the	abstract[162]	new[162]	_	_
17-8	2972-2983	information	abstract[162]	new[162]	_	_
17-9	2984-2994	concerning	_	_	_	_
17-10	2995-2998	the	abstract[163]	giv[163]	_	_
17-11	2999-3008	signaling	abstract[163]	giv[163]	_	_
17-12	3009-3017	pathways	abstract[163]	giv[163]	_	_
17-13	3018-3028	influenced	_	_	_	_
17-14	3029-3031	by	_	_	_	_
17-15	3032-3033	I	person|substance[165]	giv|giv[165]	coref	17-38[175_165]
17-16	3034-3049	supplementation	substance[165]	giv[165]	_	_
17-17	3050-3051	,	_	_	_	_
17-18	3052-3056	with	_	_	_	_
17-19	3057-3060	the	abstract[166]	new[166]	_	_
17-20	3061-3072	qualitative	abstract[166]	new[166]	_	_
17-21	3073-3083	parameters	abstract[166]	new[166]	_	_
17-22	3084-3086	of	abstract[166]	new[166]	_	_
17-23	3087-3091	milk	abstract[166]|substance|substance[168]	new[166]|giv|giv[168]	coref	17-42[0_168]
17-24	3092-3095	and	abstract[166]|substance[168]	new[166]|giv[168]	_	_
17-25	3096-3107	derivatives	abstract[166]|substance[168]|substance	new[166]|giv[168]|new	_	_
17-26	3108-3109	,	_	_	_	_
17-27	3110-3116	taking	_	_	_	_
17-28	3117-3121	into	_	_	_	_
17-29	3122-3129	account	abstract	new	ana	17-34
17-30	3130-3135	those	event[171]	giv[171]	_	_
17-31	3136-3143	studies	event[171]	giv[171]	_	_
17-32	3144-3146	in	_	_	_	_
17-33	3147-3152	which	_	_	_	_
17-34	3153-3155	it	abstract	giv	_	_
17-35	3156-3159	was	_	_	_	_
17-36	3160-3165	shown	_	_	_	_
17-37	3166-3170	that	_	_	_	_
17-38	3171-3178	dietary	abstract|substance[175]	giv|giv[175]	_	_
17-39	3179-3185	iodine	substance|substance[175]	giv|giv[175]	_	_
17-40	3186-3201	supplementation	substance[175]	giv[175]	_	_
17-41	3202-3204	in	substance[175]	giv[175]	_	_
17-42	3205-3214	ruminants	substance[175]|substance	giv[175]|giv	_	_
17-43	3215-3226	contributes	_	_	_	_
17-44	3227-3229	to	_	_	_	_
17-45	3230-3232	an	abstract[177]	new[177]	_	_
17-46	3233-3244	improvement	abstract[177]	new[177]	_	_
17-47	3245-3247	in	abstract[177]	new[177]	_	_
17-48	3248-3251	the	abstract[177]|abstract[178]	new[177]|new[178]	_	_
17-49	3252-3259	quality	abstract[177]|abstract[178]	new[177]|new[178]	_	_
17-50	3260-3262	of	abstract[177]|abstract[178]	new[177]|new[178]	_	_
17-51	3263-3268	dairy	abstract[177]|abstract[178]|substance[179]	new[177]|new[178]|new[179]	_	_
17-52	3269-3277	products	abstract[177]|abstract[178]|substance[179]	new[177]|new[178]|new[179]	_	_
17-53	3278-3279	.	_	_	_	_
